These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 16893403)

  • 21. Evidence that the anemia of renal failure participates in overall uremic toxicity.
    Kokot F; Wiecek A
    Kidney Int Suppl; 1997 Nov; 62():S83-6. PubMed ID: 9350689
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulating factors in the hematopoietic response to erythropoietin.
    Drüeke TB
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):87-92. PubMed ID: 1928086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyporesponsiveness to recombinant human erythropoietin therapy in anemic patients on hemodialysis].
    Maeda H; Hirakata H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():307-11. PubMed ID: 15250314
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of renal anemia.
    Peco-Antic A
    Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of the anemia of chronic renal failure: the role of erythropoietin.
    Chandra M; McVicar M; Clemons GK
    Adv Pediatr; 1988; 35():361-89. PubMed ID: 3055863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to recombinant human erythropoietin treatment in thalassaemic patients on chronic haemodialysis: a real clinical entity?
    Tarng DC; Huang TP; Chen TW; Fan CY; Chang JG
    Nephrol Dial Transplant; 1996 Sep; 11(9):1893-5. PubMed ID: 8918654
    [No Abstract]   [Full Text] [Related]  

  • 27. Continuous quality improvement (CQI) in rhu-Epo management: the outcome.
    Descamps C; Van Waeleghem JP; Ysebaert D
    EDTNA ERCA J; 1996; 22(3):22-6. PubMed ID: 10723328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic guidelines for renal anemia in Japan].
    Naito M; Akiba T
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():562-5. PubMed ID: 15250369
    [No Abstract]   [Full Text] [Related]  

  • 29. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European best practice guidelines 14-16: inadequate response to epoetin.
    Hörl WH; Jacobs C; Macdougall IC; Valderrábano F; Parrondo I; Thompson K; Carveth BG
    Nephrol Dial Transplant; 2000; 15 Suppl 4():43-50. PubMed ID: 11052148
    [No Abstract]   [Full Text] [Related]  

  • 31. [Should anemia be completely corrected in patients with chronic renal failure?].
    Kes P; Brunetta B
    Lijec Vjesn; 2002; 124(6-7):225-7. PubMed ID: 19658341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on the pathogenesis, pathology and treatment of the anemia of chronic renal failure.
    Brunier G
    J CANNT; 1990; ():15-7. PubMed ID: 2364042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal anemia and the effect of long-term dialysis].
    Opatrná S; Opatrný K
    Cas Lek Cesk; 1999 Feb; 138(4):107-10. PubMed ID: 10376407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of anemia in chronic renal failure (predialysis)].
    Ruedin P
    Praxis (Bern 1994); 1999 Jan; 88(5):173-7. PubMed ID: 10067374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anemia in chronic renal insufficiency].
    Feiman R; Mena Castro E; Gordillo Paniagua G
    Bol Med Hosp Infant Mex; 1981; 38(2):231-41. PubMed ID: 7259844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of renal anemia.
    Eckardt KU
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S2-8. PubMed ID: 10746799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anemia in chronic renal failure and erythropoietin].
    Rosenlöf K
    Duodecim; 1995; 111(15):1489-95. PubMed ID: 9244705
    [No Abstract]   [Full Text] [Related]  

  • 38. [Complications suffered by dialysis patients. 4. Hematologic problems].
    Akizawa T; Shiizaki K
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1366-71. PubMed ID: 11032504
    [No Abstract]   [Full Text] [Related]  

  • 39. The EPO/iron marriage: counseling needed.
    Bralow S
    Nephrol News Issues; 2007 Jun; 21(7):53, 55. PubMed ID: 17623987
    [No Abstract]   [Full Text] [Related]  

  • 40. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
    Fishbane S
    Blood Purif; 2007; 25(1):53-7. PubMed ID: 17170538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.